Choice of Vasopressor in Septic Shock: Does It Change Kidney Outcomes? A Critical Appraisal of the Evidence
Highlight
– A systematic review of randomized trials (McDonald et al., 2025) found no conclusive benefit of any specific vasopressor on incidence of acute kidney injury (AKI) in septic shock.
– Reporting was heterogeneous: only 8/17 trials reported AKI incidence using KDIGO/AKIN or undefined criteria; RRT use was the most common renal outcome but inconsistently defined.
– Existing evidence is underpowered and methodologically limited; future trials should standardize renal endpoints (KDIGO/MAKE), target subgroups at high renal risk, and include longer-term kidney outcomes.
Background: clinical context and unmet need
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.